Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailing Yang

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Cancer|June 3, 2020
Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibitionAlicia M Blessing, Janice M Santiago-O'Farrill, Weiqun Mao, et al.
Plos One|July 7, 2015
CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and ApoptosisShu Zhang, Zhen Lu, Weiqun Mao, et al.
Chemical Science|June 24, 2021
Directed evolution of cyclic peptides for inhibition of autophagyJoshua P Gray, Md Nasir Uddin, Rajan Chaudhari, et al.
Iscience|November 17, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumorsJoshua P Gray, Gamze Bildik, Ha-Neul Kim, et al.
The Journal of Clinical Investigation|June 1, 2022
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancersZhen Lu, Weiqun Mao, Hailing Yang, et al.
British Journal of Cancer|January 10, 2024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancerChae Young Han, Jacob S Bedia, Wei-Lei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2019
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast CancersHailing Yang, Zhang Shu, Yongying Jiang, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Cancer|June 3, 2020
Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibitionAlicia M Blessing, Janice M Santiago-O'Farrill, Weiqun Mao, et al.
Plos One|July 7, 2015
CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and ApoptosisShu Zhang, Zhen Lu, Weiqun Mao, et al.
Chemical Science|June 24, 2021
Directed evolution of cyclic peptides for inhibition of autophagyJoshua P Gray, Md Nasir Uddin, Rajan Chaudhari, et al.
Iscience|November 17, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumorsJoshua P Gray, Gamze Bildik, Ha-Neul Kim, et al.
The Journal of Clinical Investigation|June 1, 2022
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancersZhen Lu, Weiqun Mao, Hailing Yang, et al.
British Journal of Cancer|January 10, 2024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancerChae Young Han, Jacob S Bedia, Wei-Lei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2019
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast CancersHailing Yang, Zhang Shu, Yongying Jiang, et al.
Pageof 12